| | Class 2 Device Recall Lumipulse G pTau217/BAmyloid 142 Plasma Ratio |  |
| Date Initiated by Firm | December 11, 2025 |
| Date Posted | February 05, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1301-2026 |
| Recall Event ID |
98232 |
| 510(K)Number | K242706 |
| Product Classification |
Immunoassay blood test for amyloid pathology assessment - Product Code SET
|
| Product | Product Name: Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio
Model/Catalog Number: CL0073
Software Version: Not Applicable
Product Description: Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio is an in vitro diagnostic (IVD) test that combines the test results of the Lumipulse G pTau 217 Plasma assay and the Lumipulse G -Amyloid 1-42-N Plasma assay from the same patient specimen (K2EDTA plasma sample) into a numerical ratio. The Lumipulse G pTau 217/-Amyloid 1-42 Plasma Ratio Instructions For Use (IFU), CL0072, contains instructions on how to manually calculate the ratio and is supplied with each individual Lumipulse G assay.
Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio, Item# CL0073
is comprised of the following kits, which are imported:
Kit Description, Item#:
Imported from Fujirebio Europe (FRE):
Lumipulse G pTau 217 Plasma Immunoreaction Cartridges 81550
Lumipulse G pTau 217 Plasma Calibrators set 81557
Lumipulse pTau 217 Plasma Controls 81558
Lumipulse -Amyloid Plasma Controls 81559
Imported from Fujirebio Japan (FRI):
Lumipulse G -Amyloid 1-42-N Plasma Immunoreaction Cartridges 235447
Lumipulse G -Amyloid 1-42-N Plasma Calibrators set 235454
Component: No |
| Code Information |
Model/Catalog Number: CL0073;
UDI-DI: 00869164000086;
Distribution for Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio ("Ratio") is related to the "Ratio" Instructions for Use (IFU). Therefore, each consignee has 1 "Ratio" in which they purchase the component kits for. |
| FEI Number |
2521625
|
Recalling Firm/ Manufacturer |
Fujirebio Diagnostics, Inc. 201 Great Valley Pkwy Malvern PA 19355-1308
|
| For Additional Information Contact | Gregory Dickson 1-610-2403888 |
Manufacturer Reason for Recall | Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result). |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On or about December 11, 2025 URGENT PRODUCT CORRECTION NOTIFICATION letters were sent to customers. Actions to be taken:
- Immediately discontinue using the associated Lots listed above for the Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio.
- Review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable.
- Notify your ordering physician or health care provider as appropriate.
- The test results must be interpreted in conjunction with other diagnostic tools and clinical information.
- Please retain this letter with your laboratory records and forward this leer to those who may have received this product. |
| Quantity in Commerce | 23 units |
| Distribution | US Nationwide distribution in the states of Arizona, California, Florida, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, Pennsylvania, Texas, Washington. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = SET
|
|
|
|